Literature DB >> 28474478

Incomplete cavernous sinus syndrome as the initial manifestation of a previously undetected metastatic prostate adenocarcinoma.

María Machío Castelló1, Diego Escobar Montatixe2, Carlos Cenjor Español2, José Miguel Villacampa Aubá2, Julia Montoya Bordón1, Rafael Carias Calix3, Rafael Sáez Pinel1.   

Abstract

BACKGROUND: Cavernous sinus syndrome presents as unilateral ophthalmoplegia associated with sympathetic denervation, pain, paresthesias, and V1 and V2 distribution numbness. The etiology may be vascular, inflammatory, infectious, and, less commonly, neoplastic (metastatic).
METHODS: We report a patient with incomplete cavernous sinus syndrome as the initial manifestation of previously undetected metastatic prostate adenocarcinoma.
RESULTS: A 59-year-old man presented with a 2-month history of left hemicranial headaches with ptosis and binocular diplopia. Clinical evaluation found left third, fourth, and sixth cranial nerve palsy with mydriasis and ptosis. An MRI showed an enhancing lesion at the clivus with infiltration of left cavernous sinus. A trans-sphenoidal biopsy was performed, leading to diagnosis of metastatic prostate adenocarcinoma. The patient underwent treatment and achieved clinical improvement.
CONCLUSIONS: In middle-aged men, it is important to include metastatic prostate adenocarcinoma in the differential diagnosis of cavernous sinus syndrome, even in the absence of primary tumor diagnosis.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  clivus; cranial nerve palsy; metastasis; prostatic carcinoma; skull base metastasis

Mesh:

Year:  2017        PMID: 28474478     DOI: 10.1002/hed.24808

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  Cranial nerve palsy caused by metastasis to the skull base in patients with castration-resistant prostate cancer: Three case reports.

Authors:  Yota Yasumizu; Takeo Kosaka; Hiroshi Hongo; Ryuichi Mizuno; Mototsugu Oya
Journal:  IJU Case Rep       Date:  2021-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.